Results 61 to 70 of about 85,679 (96)

GLP-1 and dual GIP/GLP-1 receptor agonists' psychopharmacology and putative neuropsychiatric associated effects: a Bradford Hill-informed, systematic, evaluation. [PDF]

Curr Psychiatry Rep
Schifano F, De Luca MA, Bonaccorso S, Arillotta D, Floresta G, Martinotti G, Papanti GD, Corkery JM, Chiappini S, Guirguis A.   +9 more
europepmc   +1 more source

Patient-Reported Continuity of GLP-1 Receptor Agonist Therapy. [PDF]

Obes Sci Pract
Chen Y, Piantek G, Zhang X, Feng Y, Yan C, Samuels JM, Rosenbloom ST, Yu D, Novak LL, Srivastava G.   +9 more
europepmc   +1 more source

GLP-1 Receptor Agonist Coverage for Obesity in Medicaid and Total GLP-1 Receptor Agonist Utilization.

JAMA Health Forum
Khanna R, Wang MC, Venkataramani AS.
europepmc   +1 more source

GLP-1-Based Therapy for Obstructive Sleep Apnoea. [PDF]

Respirology
Zheng Y, Yee BJ.
europepmc   +1 more source

Gastrointestinal adverse effects of GLP-1 receptor agonists and dual GIP/GLP-1 receptor agonists: A narrative expert review of approved therapies, oral formulations, and pipeline agents. [PDF]

Nutr Clin Pract
Singhani V, Ehsan M, Valencia S, Nadeem A, Moazzam E, Butsch WS, Garg S.   +6 more
europepmc   +1 more source

Unanticipated Effects of GLP-1 Receptor Agonists: A Net Positive. [PDF]

Obesity (Silver Spring)
Gilden AH, Heymsfield SB.
europepmc   +1 more source

Effects of GLP-1 receptor agonists on body weight and cardiovascular outcomes: a review. [PDF]

Neth Heart J
van Maren SJF, van Doorn EPM, Smits MM, Tack CJJ, van Rossum EFC, El Messaoudi S.   +5 more
europepmc   +1 more source

Incretin-Based Therapies in Doxorubicin-Induced Cardiotoxicity: A Systematic Review of GLP-1 and Dual GIP/GLP-1 Agonists. [PDF]

Cardiovasc Toxicol
Khatami S, Faghihi M, Tavakoli G, Szmit S, Yousefifard M.   +4 more
europepmc   +1 more source

GLP-1 and GLP-1/GIP receptor agonist medication use and self-reported outcomes in individuals with lipedema: Results from a large online survey. [PDF]

Obes Pillars
Srinivasan A, Kartt J, Daftuar F, Harmacek LD, Samouhos E, Galia S, Heil S, Clark E, Mascio C, Cochrane JC.   +9 more
europepmc   +1 more source

Multisystem Benefits of GLP-1 Microdosing: A Narrative Review. [PDF]

Cureus
Panlilio MA, Piserchio N, Hennessey M, Torres K, Khan S, Choy L.   +5 more
europepmc   +1 more source